US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Longeveron Inc

1.61

+0.05003.21%

Post-market: 1.610.00000.00%16:11 EDT

Volume:134.08K

Turnover:213.04K

Market Cap:24.03M

PE:-0.62

High:1.61

Open:1.55

Low:1.54

Close:1.56

Loading ...

Overview Company News Filings

Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025

Longeveron Files $70 Million Mixed Shelf

MT Newswires Live

BRIEF-Longeveron Inc Files For Mixed Shelf Of Up To $70 Million - SEC Filing

Longeveron Inc Files for Mixed Shelf of up to $70 Mln - SEC Filing

THOMSON REUTERS

Longeveron’s Promising Alzheimer’s Program: Buy Rating Backed by FDA Alignment and Strategic Advancements

Longeveron Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Longeveron Inc: Company Anticipates Initiating Pivotal Clinical Trial in Second Half of 2026

THOMSON REUTERS

Longeveron® Announces Positive Type B Meeting With U.S. FDA Regarding Pathway to Bla for Laromestrocel (Lomecel-Btm) in Alzheimer’s Disease

THOMSON REUTERS

Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease

LGVN Announces Positive Alzheimer’s News

Zacks Small Cap Research

Roth MKM Keeps Their Buy Rating on Longeveron (LGVN)

Longeveron® Announces Nature Medicine Publication Of Results Of Phase 2A Clinical Trial Evaluating Laromestrocel (Lomecel-B™) In Alzheimer’S Disease

Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease

Longeveron’s Clinical Advancements and Strategic Positioning Earn a Buy Rating

Longeveron® to Present at the 37th Annual Roth Conference

Roth MKM Sticks to Its Buy Rating for Longeveron (LGVN)

Longeveron Inc. Earnings Call: Growth and Challenges

Promising Outlook for Longeveron: ELPIS II Trial Progress and Financial Strength Highlighted

LGVN Well Positioned for Critical 2025

Zacks Small Cap Research

Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LGVN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LGVN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGVN\",,,,,undefined,":{"symbol":"LGVN","market":"US","secType":"STK","nameCN":"Longeveron Inc","latestPrice":1.61,"timestamp":1745438400000,"preClose":1.56,"halted":0,"volume":134082,"hourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.61,"latestTime":"16:11 EDT","volume":800,"amount":1288.03008,"timestamp":1745439113480},"delay":0,"floatShares":12276134,"shares":14927903,"eps":-2.61636,"marketStatus":"Post-Mkt","change":0.05,"latestTime":"04-23 19:17:59 EDT","open":1.55,"high":1.61,"low":1.54,"amount":213039.0652,"amplitude":0.044872,"askPrice":1.7,"askSize":100,"bidPrice":1.58,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.61636,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"listingDate":1613106000000,"exchange":"NASDAQ","adjPreClose":1.56,"preHourTrading":{"tag":"盘前","latestPrice":1.55,"preClose":1.54,"latestTime":"09:03 EDT","volume":206,"amount":324.220001,"timestamp":1745413432752},"postHourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.61,"latestTime":"16:11 EDT","volume":800,"amount":1288.03008,"timestamp":1745439113480},"volumeRatio":1.738205},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGVN\",,,,,undefined,":{"symbol":"LGVN","floatShares":12276134,"roa":"-54.87%","roe":"-111.59%","lyrEps":-2.61636,"volumeRatio":1.738205,"shares":14927903,"dividePrice":0,"high":1.61,"amplitude":0.044872,"preClose":1.56,"low":1.54,"week52Low":0.7707,"pbRate":"1.10","psRate":"10.05","week52High":6.4,"institutionHeld":0,"latestPrice":1.61,"eps":-2.61636,"divideRate":0,"volume":134082,"delay":0,"ttmEps":-2.61636,"open":1.55,"prevYearClose":1.73,"prevWeekClose":1.46,"prevMonthClose":1.55,"prevQuarterClose":1.55,"fiveDayClose":1.46,"twentyDayClose":1.78,"sixtyDayClose":1.59},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LGVN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529552636","title":"Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529552636","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529552636?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:05","pubTimestamp":1745352300,"startTime":"0","endTime":"0","summary":"MIAMI, April 22, 2025  -- Longeveron Inc. , a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders.Twenty twenty-four was a year of execution for Longeveron. We made significant progress advancing Longeveron’s founding mission - developing cutting-edge cellular therapy research to impact patients’ lives for the better by addressing unmet medical needs. We have come a long way pursuing that mission and now have clarity on the pathway to our first potential Biological License Application  submission.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/longeveron-issues-letter-shareholders-highlighting-200500369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRGS","IE00BZ1G4Q59.USD","BK4218","IE00B1BXHZ80.USD","BK4181","BK4596","BK4023","LU0170899867.USD","BK4588","BK4595","INN","BK4585","BK4600","LU2065732104.USD","LU0149725797.USD","LU0971096721.USD","IE00BHPRN162.USD","LU0267386448.USD","LGVN","BK4139","STRK","BK4006","BK4097","BK4516","LU0882574139.USD","IE00BKVL7J92.USD","LU1363072403.SGD","CMC"],"gpt_icon":1},{"id":"2523063366","title":"Longeveron Files $70 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2523063366","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523063366?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:43","pubTimestamp":1743194595,"startTime":"0","endTime":"0","summary":"Longeveron  on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $70 million in securities from time to time in one or more offerings.The filing covers class A common stock, preferred stock, warrants, purchase contracts, and units.The company plans to use the net proceeds for general corporate purposes.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LGVN"],"gpt_icon":0},{"id":"2523680932","title":"BRIEF-Longeveron Inc Files For Mixed Shelf Of Up To $70 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2523680932","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523680932?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:07","pubTimestamp":1743192460,"startTime":"0","endTime":"0","summary":"BRIEF-Longeveron Inc Files For Mixed Shelf Of Up To $70 Million - SEC FilingMarch 28 (Reuters) - Longeveron Inc LGVN.O:LONGEVERON INC FILES FOR MIXED SHELF OF UP TO $70 MILLION - SEC FILINGSource text: [ID:n0001013762-25-004079]Further company coverage: LGVN.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB1C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2523806166","title":"Longeveron Inc Files for Mixed Shelf of up to $70 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2523806166","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523806166?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:06","pubTimestamp":1743192410,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB1C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"gpt_icon":0},{"id":"2521248969","title":"Longeveron’s Promising Alzheimer’s Program: Buy Rating Backed by FDA Alignment and Strategic Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2521248969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521248969?lang=en_us&edition=fundamental","pubTime":"2025-03-22 23:45","pubTimestamp":1742658307,"startTime":"0","endTime":"0","summary":"Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Longeveron (LGVN – Research Report). The associated price target rema...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/longeverons-promising-alzheimers-program-buy-rating-backed-by-fda-alignment-and-strategic-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/longeverons-promising-alzheimers-program-buy-rating-backed-by-fda-alignment-and-strategic-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN"],"gpt_icon":0},{"id":"2521286653","title":"Longeveron Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2521286653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521286653?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:42","pubTimestamp":1742560920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LGVN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 08:42 ET (12:42 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN"],"gpt_icon":0},{"id":"2520459015","title":"Longeveron Inc: Company Anticipates Initiating Pivotal Clinical Trial in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2520459015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520459015?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:00","pubTimestamp":1742475602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUABCBXWW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2520110459","title":"Longeveron® Announces Positive Type B Meeting With U.S. FDA Regarding Pathway to Bla for Laromestrocel (Lomecel-Btm) in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2520110459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520110459?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:00","pubTimestamp":1742475602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUABCBXWW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2520451633","title":"Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2520451633","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520451633?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:00","pubTimestamp":1742475600,"startTime":"0","endTime":"0","summary":"Nataliya Agafonova, M.D., Chief Medical Officer, Longeveron","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/20/3046277/0/en/Longeveron-Announces-Positive-Type-B-Meeting-with-U-S-FDA-Regarding-Pathway-to-BLA-for-Laromestrocel-Lomecel-BTM-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4575","BTM","MSC","AAIC","ARIA","BK4110","BK4150","BK4139","LGVN","BK4137"],"gpt_icon":0},{"id":"2520234465","title":"LGVN Announces Positive Alzheimer’s News","url":"https://stock-news.laohu8.com/highlight/detail?id=2520234465","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520234465?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:05","pubTimestamp":1742468700,"startTime":"0","endTime":"0","summary":"Longeveron  is a company that should be getting more attention from investors and the just released annual results again proved that point. LGVN has made substantial progress with its signature treatment, Lomecel-B, in treating both HLHS and Alzheimer's Disease and we suggest investors take a look at this stock before more good news comes out—such as what happened recently.We continue to believe that Longeveron is an exciting clinical-stage company and investors aren’t appropriately appreciating the game-changing potential Lomecel-B may be able to have on multiple serious medical conditions. As a result of the prudent decisions made by management, we believe Lomecel-B will ulti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lgvn-announces-positive-alzheimer-news-110500532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4218","BK4181","INN","ARIA","LGVN","BK4139"],"gpt_icon":0},{"id":"2518704909","title":"Roth MKM Keeps Their Buy Rating on Longeveron (LGVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518704909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518704909?lang=en_us&edition=fundamental","pubTime":"2025-03-12 07:55","pubTimestamp":1741737303,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on Longeveron (LGVN – Research Report) today and set a price target of $10.00. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-longeveron-lgvn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-longeveron-lgvn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN"],"gpt_icon":0},{"id":"2518740787","title":"Longeveron® Announces Nature Medicine Publication Of Results Of Phase 2A Clinical Trial Evaluating Laromestrocel (Lomecel-B™) In Alzheimer’S Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740787?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:30","pubTimestamp":1741703411,"startTime":"0","endTime":"0","summary":"March 11 (Reuters) - Longeveron Inc ::*LONGEVERON ANNOUNCES NATURE MEDICINE PUBLICATION OF RESULTS OF PHASE 2A CLINICAL TRIAL EVALUATING LAROMESTROCEL (LOMECEL-B) IN ALZHEIMER’S DISEASE*LONGEVERON INC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nRSDb5VKT0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"gpt_icon":0},{"id":"2518459727","title":"Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2518459727","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518459727?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:30","pubTimestamp":1741696200,"startTime":"0","endTime":"0","summary":"Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Chairman, Longeveron","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040564/0/en/Longeveron-Announces-Nature-Medicine-Publication-of-Results-of-Phase-2a-Clinical-Trial-Evaluating-Laromestrocel-Lomecel-B-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INN","PET","BK4150","BK4139","LGVN","BK4218","MSC","BK4192","BK4575","BK4181","ARIA"],"gpt_icon":0},{"id":"2517394103","title":"Longeveron’s Clinical Advancements and Strategic Positioning Earn a Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517394103","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517394103?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:35","pubTimestamp":1741192554,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Michael Okunewitch has maintained their bullish stance on LGVN stock, giving a Buy rating yesterday. Michael Okunewitch has giv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/longeverons-clinical-advancements-and-strategic-positioning-earn-a-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/longeverons-clinical-advancements-and-strategic-positioning-earn-a-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN"],"gpt_icon":0},{"id":"2517838910","title":"Longeveron® to Present at the 37th Annual Roth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2517838910","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517838910?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:25","pubTimestamp":1741184700,"startTime":"0","endTime":"0","summary":"MIAMI, March 05, 2025  -- Longeveron Inc. , a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the 37th Annual Roth Conference taking place March 17-18, 2025.Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B, an allogeneic medicinal signaling cell  therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome , Alzheimer’s disease, and Aging-related Frailty. Lomecel-Bdevelopment programs have r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/longeveron-present-37th-annual-roth-142500458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4575","MSC","BK4150","BK4139","LGVN"],"gpt_icon":0},{"id":"2516879603","title":"Roth MKM Sticks to Its Buy Rating for Longeveron (LGVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516879603","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516879603?lang=en_us&edition=fundamental","pubTime":"2025-03-04 23:15","pubTimestamp":1741101353,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on Longeveron (LGVN – Research Report) today and set a price target of $10.00. The c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-its-buy-rating-for-longeveron-lgvn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-its-buy-rating-for-longeveron-lgvn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN"],"gpt_icon":0},{"id":"2516696658","title":"Longeveron Inc. Earnings Call: Growth and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2516696658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516696658?lang=en_us&edition=fundamental","pubTime":"2025-03-04 08:39","pubTimestamp":1741048795,"startTime":"0","endTime":"0","summary":"Longeveron Inc. (($LGVN)) has held its Q4 earnings call. Read on for the main highlights of the call. The latest earnings call from Longeveron Inc....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-inc-earnings-call-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-inc-earnings-call-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN"],"gpt_icon":0},{"id":"2516638070","title":"Promising Outlook for Longeveron: ELPIS II Trial Progress and Financial Strength Highlighted","url":"https://stock-news.laohu8.com/highlight/detail?id=2516638070","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516638070?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:45","pubTimestamp":1741005940,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. W...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-outlook-for-longeveron-elpis-ii-trial-progress-and-financial-strength-highlighted?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-outlook-for-longeveron-elpis-ii-trial-progress-and-financial-strength-highlighted?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","LU2065732104.USD","BK4139","PRGS","BK4097"],"gpt_icon":0},{"id":"2516563616","title":"LGVN Well Positioned for Critical 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516563616","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516563616?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:50","pubTimestamp":1741002600,"startTime":"0","endTime":"0","summary":"Longeveron  is a company that should be getting more attention from investors and the just released annual results again proved that point. LGVN has made substantial progress with its signature treatment, Lomecel-B, in treating both HLHS and Alzheimer's Disease and we suggest investors take a look at this stock before more good news comes out—such as what happened recently. The company announced that Lomecel-B has been granted an International Non-proprietary Name  of “laromestrocel” on the INN List issued by the World Health Organization. This is an important step in the commercialization potential of Lomecel-B and follows the therapy being the first cellular therapeutic candidate to receive U.S. FDA Regenerative Medicine Advanced Therapy  designation for Alzheimer’s disease.To assess long-term survival benefits, all ELPIS I patients  wer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lgvn-well-positioned-critical-2025-115000011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INN","BK4139","LGVN","BK4218","MACE","BK4157","BK4181","BK4183"],"gpt_icon":0},{"id":"2516851451","title":"Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long","url":"https://stock-news.laohu8.com/highlight/detail?id=2516851451","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516851451?lang=en_us&edition=fundamental","pubTime":"2025-03-02 20:14","pubTimestamp":1740917676,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at Longeveron Inc.'s  future prospects. Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The US$23m market-cap company announced a latest loss of US$16m on 31 December 2024 for its most recent financial year result. As path to profitability is the topic on Longeveron's investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.Consensus from 4 of the American Biotechs analysts is that Longeveron is on the verge of breakeven. They expect the company to post a final loss in 2026, before turning a profit of US$750k in 2027. The company is therefore projected to breakeven around 2 years from now. In order to meet this breakeven date, we calculated the rate at which the company must grow ye","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analysts-expect-breakeven-longeveron-inc-121436724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","IE00BKPKM429.USD","TQQQ","IE00BGHQF748.EUR","QID","LU2210150020.SGD","BK4588","USJW.SI","SQQQ","IE00B3QW5Z07.USD","BK4585","NQmain","LU2095319765.USD","NDAQ","NVIW.SI","BK4112","MNQmain","LGVN",".IXIC","QLD","BK4139","LU2210149790.SGD","TSYW.SI","IE00B64PRP62.GBP"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LGVN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-28","symbol":"LGVN","fiscalQuarterEnding":"2024/12","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"post","actualEps":-2.5},{"market":"US","date":"2024-11-12","symbol":"LGVN","fiscalQuarterEnding":"2024/09","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-05-14","symbol":"LGVN","fiscalQuarterEnding":"2024/03","expectedEps":-2.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-1.61},{"market":"US","date":"2024-03-27","symbol":"LGVN","defaultRemindTime":1711546200000,"type":"split","dateTimestamp":1711512000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2023-08-18","symbol":"LGVN","defaultRemindTime":1692365400000,"type":"split","dateTimestamp":1692331200000,"forFactor":1040792,"toFactor":1000000,"ratio":1.040792}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LGVN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LGVN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1733457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LGVN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LGVN","date":"2025-04-22","current":-1.420548,"percent":0.830904,"low":-65.336046,"twenty":-10.10532,"median":-3.822093,"eighty":-1.506493,"high":-0.238289,"avg":-7.877982,"sd":10.571336,"marketCap":22690412},"quantilePoints":[{"date":"2021-02-12","current":-48.831667,"twenty":-61.328463,"median":-55.317089,"eighty":-51.425836,"marketCap":138618210},{"date":"2021-02-19","current":-40.594206,"twenty":-54.151804,"median":-48.831667,"eighty":-45.207185,"marketCap":115234571},{"date":"2021-02-26","current":-52.719749,"twenty":-52.258451,"median":-48.666918,"eighty":-44.877686,"marketCap":149655288},{"date":"2021-03-05","current":-45.009486,"twenty":-52.61431,"median":-48.831667,"eighty":-45.035846,"marketCap":127768202},{"date":"2021-03-12","current":-53.510545,"twenty":-53.352386,"median":-48.666918,"eighty":-45.194005,"marketCap":151900117},{"date":"2021-03-19","current":-47.948307,"twenty":-52.61431,"median":-49.016793,"eighty":-45.418064,"marketCap":136110620},{"date":"2021-03-26","current":-39.266859,"twenty":-52.166192,"median":-48.49236,"eighty":-45.035846,"marketCap":111466636},{"date":"2021-04-01","current":-33.063787,"twenty":-52.060752,"median":-47.665091,"eighty":-41.136709,"marketCap":123030352},{"date":"2021-04-09","current":-34.694051,"twenty":-50.619522,"median":-46.12978,"eighty":-37.797691,"marketCap":129096563},{"date":"2021-04-16","current":-33.216624,"twenty":-50.419181,"median":-45.437833,"eighty":-35.254454,"marketCap":123599059},{"date":"2021-04-23","current":-30.057988,"twenty":-50.41326,"median":-45.009486,"eighty":-33.62419,"marketCap":111845774},{"date":"2021-04-30","current":-31.331632,"twenty":-49.490664,"median":-41.755104,"eighty":-33.063787,"marketCap":116585002},{"date":"2021-05-07","current":-28.47867,"twenty":-49.283915,"median":-40.594206,"eighty":-31.433523,"marketCap":105969132},{"date":"2021-05-14","current":-15.200628,"twenty":-49.016793,"median":-37.978026,"eighty":-31.076903,"marketCap":100612958},{"date":"2021-05-21","current":-18.326795,"twenty":-48.831667,"median":-36.37526,"eighty":-30.007042,"marketCap":121305057},{"date":"2021-05-28","current":-18.929084,"twenty":-48.502169,"median":-34.617632,"eighty":-28.071104,"marketCap":125291608},{"date":"2021-06-04","current":-19.33061,"twenty":-48.486474,"median":-33.878919,"eighty":-26.899352,"marketCap":127949308},{"date":"2021-06-11","current":-20.248384,"twenty":-48.055156,"median":-33.318516,"eighty":-19.405179,"marketCap":134024053},{"date":"2021-06-18","current":-20.64991,"twenty":-47.495161,"median":-32.758112,"eighty":-19.405179,"marketCap":136681754},{"date":"2021-06-25","current":-22.514138,"twenty":-46.432919,"median":-31.484469,"eighty":-19.62315,"marketCap":149021079},{"date":"2021-07-02","current":-23.804757,"twenty":-46.14296,"median":-31.22974,"eighty":-19.881274,"marketCap":157563689},{"date":"2021-07-09","current":-21.424282,"twenty":-45.738372,"median":-31.076903,"eighty":-20.12219,"marketCap":141807320},{"date":"2021-07-16","current":-18.01131,"twenty":-45.473443,"median":-30.210826,"eighty":-19.571525,"marketCap":119216863},{"date":"2021-07-23","current":-17.753186,"twenty":-45.431244,"median":-29.675895,"eighty":-19.238833,"marketCap":117508341},{"date":"2021-07-30","current":-16.462567,"twenty":-45.246725,"median":-28.47867,"eighty":-18.946292,"marketCap":108965731},{"date":"2021-08-06","current":-16.921454,"twenty":-45.062206,"median":-27.485228,"eighty":-18.625072,"marketCap":112003104},{"date":"2021-08-13","current":-7.15835,"twenty":-44.890866,"median":-26.491786,"eighty":-17.999838,"marketCap":74547057},{"date":"2021-08-20","current":-6.552643,"twenty":-43.348813,"median":-23.532293,"eighty":-17.667145,"marketCap":68239229},{"date":"2021-08-27","current":-6.479224,"twenty":-41.631425,"median":-22.973025,"eighty":-17.414758,"marketCap":67474643},{"date":"2021-09-03","current":-6.864674,"twenty":-41.056573,"median":-22.169973,"eighty":-16.909982,"marketCap":71488716},{"date":"2021-09-10","current":-6.846319,"twenty":-40.839572,"median":-21.625045,"eighty":-16.577289,"marketCap":71297569},{"date":"2021-09-17","current":-6.644417,"twenty":-40.063267,"median":-21.280879,"eighty":-16.330637,"marketCap":69194960},{"date":"2021-09-24","current":-6.791255,"twenty":-38.82346,"median":-20.965394,"eighty":-15.326822,"marketCap":70724131},{"date":"2021-10-01","current":-6.699481,"twenty":-38.014093,"median":-20.64991,"eighty":-7.048222,"marketCap":69768399},{"date":"2021-10-08","current":-6.277322,"twenty":-37.595528,"median":-20.305745,"eighty":-6.864674,"marketCap":65372034},{"date":"2021-10-15","current":-7.305188,"twenty":-36.925474,"median":-19.674775,"eighty":-6.853661,"marketCap":76076227},{"date":"2021-10-22","current":-6.185549,"twenty":-35.926938,"median":-19.34495,"eighty":-6.813281,"marketCap":64416303},{"date":"2021-10-29","current":-6.332386,"twenty":-35.030293,"median":-19.101167,"eighty":-6.706823,"marketCap":65945473},{"date":"2021-11-05","current":-7.15835,"twenty":-34.632916,"median":-18.979275,"eighty":-6.706823,"marketCap":74547057},{"date":"2021-11-12","current":-4.536013,"twenty":-34.378188,"median":-18.929084,"eighty":-6.677456,"marketCap":65010142},{"date":"2021-11-19","current":-13.381239,"twenty":-33.929865,"median":-18.584919,"eighty":-6.651759,"marketCap":191779918},{"date":"2021-11-26","current":-40.917508,"twenty":-34.663484,"median":-18.871723,"eighty":-6.662772,"marketCap":586429722},{"date":"2021-12-03","current":-28.484032,"twenty":-34.955363,"median":-18.957764,"eighty":-6.670114,"marketCap":408233150},{"date":"2021-12-10","current":-27.507194,"twenty":-34.663484,"median":-19.086827,"eighty":-6.699481,"marketCap":394233106},{"date":"2021-12-17","current":-24.619151,"twenty":-34.459701,"median":-19.33061,"eighty":-6.699481,"marketCap":352841674},{"date":"2021-12-23","current":-19.395191,"twenty":-34.133648,"median":-19.395191,"eighty":-6.699481,"marketCap":277971876},{"date":"2021-12-31","current":-17.087588,"twenty":-33.62419,"median":-19.33061,"eighty":-6.717836,"marketCap":244899310},{"date":"2022-01-07","current":-13.718204,"twenty":-33.573245,"median":-19.072486,"eighty":-6.754546,"marketCap":196609305},{"date":"2022-01-14","current":-12.854623,"twenty":-33.318516,"median":-18.943424,"eighty":-6.791255,"marketCap":184232455},{"date":"2022-01-21","current":-9.315354,"twenty":-33.237002,"median":-18.871723,"eighty":-6.791255,"marketCap":133507660},{"date":"2022-01-28","current":-9.980737,"twenty":-33.094354,"median":-18.384156,"eighty":-6.820623,"marketCap":143043921},{"date":"2022-02-04","current":-10.561177,"twenty":-32.574708,"median":-18.169052,"eighty":-6.842648,"marketCap":151362788},{"date":"2022-02-11","current":-9.86748,"twenty":-31.881846,"median":-17.937012,"eighty":-6.861003,"marketCap":141420728},{"date":"2022-02-18","current":-9.088841,"twenty":-31.535415,"median":-17.710166,"eighty":-6.864674,"marketCap":130261273},{"date":"2022-02-25","current":-8.749072,"twenty":-31.453901,"median":-17.660508,"eighty":-6.8867,"marketCap":125391693},{"date":"2022-03-04","current":-8.720757,"twenty":-31.372388,"median":-17.581104,"eighty":-6.901384,"marketCap":124985894},{"date":"2022-03-11","current":-8.219862,"twenty":-31.209362,"median":-17.333064,"eighty":-6.934422,"marketCap":140107545},{"date":"2022-03-18","current":-8.416157,"twenty":-31.097281,"median":-17.087588,"eighty":-6.956448,"marketCap":143453397},{"date":"2022-03-25","current":-8.268936,"twenty":-31.076903,"median":-16.921454,"eighty":-6.967461,"marketCap":140944008},{"date":"2022-04-01","current":-19.151051,"twenty":-31.033156,"median":-16.921454,"eighty":-6.985815,"marketCap":326429670},{"date":"2022-04-08","current":-11.728639,"twenty":-30.803199,"median":-16.83276,"eighty":-6.993157,"marketCap":199914647},{"date":"2022-04-14","current":-12.03535,"twenty":-30.485933,"median":-16.60597,"eighty":-7.000499,"marketCap":205142540},{"date":"2022-04-22","current":-15.163805,"twenty":-30.149691,"median":-16.462567,"eighty":-7.04088,"marketCap":258467054},{"date":"2022-04-29","current":-12.292987,"twenty":-30.03761,"median":-16.347845,"eighty":-7.114299,"marketCap":209533971},{"date":"2022-05-06","current":-10.268693,"twenty":-29.742124,"median":-16.290485,"eighty":-7.15835,"marketCap":175029874},{"date":"2022-05-13","current":-9.602157,"twenty":-29.283613,"median":-15.640536,"eighty":-7.15835,"marketCap":167500032},{"date":"2022-05-20","current":-9.830208,"twenty":-28.982376,"median":-15.171948,"eighty":-7.160402,"marketCap":171478157},{"date":"2022-05-27","current":-9.662171,"twenty":-28.594457,"median":-14.735002,"eighty":-7.213071,"marketCap":168546907},{"date":"2022-06-03","current":-10.478354,"twenty":-28.48296,"median":-14.280476,"eighty":-7.291006,"marketCap":182784409},{"date":"2022-06-10","current":-8.605933,"twenty":-28.397157,"median":-13.986034,"eighty":-7.348262,"marketCap":150121903},{"date":"2022-06-17","current":-7.225623,"twenty":-28.000793,"median":-13.490192,"eighty":-7.348262,"marketCap":126043774},{"date":"2022-06-24","current":-8.149831,"twenty":-27.71955,"median":-13.34012,"eighty":-7.28746,"marketCap":142165652},{"date":"2022-07-01","current":-7.129602,"twenty":-27.714484,"median":-12.897094,"eighty":-7.237626,"marketCap":124368773},{"date":"2022-07-08","current":-8.689952,"twenty":-27.548652,"median":-12.771457,"eighty":-7.277493,"marketCap":151587528},{"date":"2022-07-15","current":-7.585704,"twenty":-27.306321,"median":-12.480832,"eighty":-7.295604,"marketCap":132325025},{"date":"2022-07-22","current":-7.393661,"twenty":-27.255998,"median":-12.243914,"eighty":-7.303678,"marketCap":128975024},{"date":"2022-07-29","current":-7.47768,"twenty":-27.05219,"median":-11.992411,"eighty":-7.295604,"marketCap":130440649},{"date":"2022-08-05","current":-7.261631,"twenty":-26.986954,"median":-11.728639,"eighty":-7.295604,"marketCap":126671899},{"date":"2022-08-12","current":-6.915094,"twenty":-26.590105,"median":-11.385117,"eighty":-7.261631,"marketCap":124872769},{"date":"2022-08-19","current":-6.13642,"twenty":-25.956359,"median":-10.955726,"eighty":-7.223223,"marketCap":110811465},{"date":"2022-08-26","current":-6.043444,"twenty":-25.233568,"median":-10.809898,"eighty":-7.162453,"marketCap":109132504},{"date":"2022-09-02","current":-5.334501,"twenty":-25.01838,"median":-10.575334,"eighty":-7.129602,"marketCap":96330421},{"date":"2022-09-09","current":-5.903979,"twenty":-24.772047,"median":-10.504549,"eighty":-7.055563,"marketCap":106614061},{"date":"2022-09-16","current":-5.299635,"twenty":-24.568186,"median":-10.355899,"eighty":-6.985815,"marketCap":95700811},{"date":"2022-09-23","current":-4.695291,"twenty":-24.222196,"median":-10.150622,"eighty":-6.90961,"marketCap":84787560},{"date":"2022-09-30","current":-4.300143,"twenty":-23.952453,"median":-10.086915,"eighty":-6.861598,"marketCap":77651974},{"date":"2022-10-07","current":-4.067702,"twenty":-23.847373,"median":-10.023208,"eighty":-6.791255,"marketCap":73454570},{"date":"2022-10-14","current":-4.021214,"twenty":-23.77034,"median":-9.994894,"eighty":-6.699481,"marketCap":72615089},{"date":"2022-10-21","current":-4.207166,"twenty":-23.489272,"median":-9.909952,"eighty":-6.65543,"marketCap":75973012},{"date":"2022-10-28","current":-4.195544,"twenty":-23.145108,"median":-9.827609,"eighty":-6.570998,"marketCap":75763142},{"date":"2022-11-04","current":-3.835262,"twenty":-22.996298,"median":-9.806203,"eighty":-6.534289,"marketCap":69257166},{"date":"2022-11-11","current":-4.544205,"twenty":-22.973244,"median":-9.732066,"eighty":-6.479224,"marketCap":82059248},{"date":"2022-11-18","current":-4.568971,"twenty":-22.886984,"median":-9.640967,"eighty":-6.446186,"marketCap":84283804},{"date":"2022-11-25","current":-4.888001,"twenty":-22.741313,"median":-9.602157,"eighty":-6.405805,"marketCap":90168957},{"date":"2022-12-02","current":-4.284122,"twenty":-22.570963,"median":-9.514769,"eighty":-6.387451,"marketCap":79029202},{"date":"2022-12-09","current":-3.714425,"twenty":-22.444428,"median":-9.458125,"eighty":-6.332386,"marketCap":68520000},{"date":"2022-12-16","current":-3.543516,"twenty":-22.13424,"median":-9.422117,"eighty":-6.284664,"marketCap":65367239},{"date":"2022-12-23","current":-3.725819,"twenty":-21.802864,"median":-9.371983,"eighty":-6.176991,"marketCap":68730184},{"date":"2022-12-30","current":-3.668849,"twenty":-21.711086,"median":-9.315354,"eighty":-6.138904,"marketCap":67679264},{"date":"2023-01-06","current":-4.067637,"twenty":-21.481642,"median":-9.182063,"eighty":-6.043444,"marketCap":75035705},{"date":"2023-01-13","current":-4.215759,"twenty":-21.424282,"median":-9.117155,"eighty":-5.915601,"marketCap":77768098},{"date":"2023-01-20","current":-4.500607,"twenty":-21.30956,"median":-9.000806,"eighty":-5.678512,"marketCap":83022699},{"date":"2023-01-27","current":-4.73988,"twenty":-21.234991,"median":-8.893998,"eighty":-5.548346,"marketCap":87436564},{"date":"2023-02-03","current":-4.603153,"twenty":-21.085853,"median":-8.803446,"eighty":-5.274067,"marketCap":84914356},{"date":"2023-02-10","current":-4.113213,"twenty":-20.91377,"median":-8.720757,"eighty":-4.912766,"marketCap":75876442},{"date":"2023-02-17","current":-4.033455,"twenty":-20.741687,"median":-8.605933,"eighty":-4.827782,"marketCap":74405153},{"date":"2023-02-24","current":-3.93091,"twenty":-20.672854,"median":-8.569513,"eighty":-4.694896,"marketCap":72513497},{"date":"2023-03-03","current":-4.090425,"twenty":-20.598285,"median":-8.416157,"eighty":-4.68291,"marketCap":75456073},{"date":"2023-03-10","current":-3.437042,"twenty":-20.443411,"median":-8.263395,"eighty":-4.603153,"marketCap":64736687},{"date":"2023-03-17","current":-3.126922,"twenty":-20.294273,"median":-8.219862,"eighty":-4.553749,"marketCap":58895578},{"date":"2023-03-24","current":-3.093419,"twenty":-20.059093,"median":-8.166443,"eighty":-4.540928,"marketCap":58264553},{"date":"2023-03-31","current":-2.981744,"twenty":-19.778025,"median":-7.99903,"eighty":-4.512001,"marketCap":56161140},{"date":"2023-04-06","current":-2.8589,"twenty":-19.571525,"median":-7.957788,"eighty":-4.498873,"marketCap":53847385},{"date":"2023-04-14","current":-3.13809,"twenty":-19.408067,"median":-7.93795,"eighty":-4.455031,"marketCap":59105919},{"date":"2023-04-21","current":-3.171592,"twenty":-19.380831,"median":-7.819121,"eighty":-4.404835,"marketCap":59736943},{"date":"2023-04-28","current":-3.13809,"twenty":-19.347819,"median":-7.681726,"eighty":-4.316523,"marketCap":59105919},{"date":"2023-05-05","current":-3.319422,"twenty":-19.33061,"median":-7.645718,"eighty":-4.210603,"marketCap":62521321},{"date":"2023-05-12","current":-3.855895,"twenty":-19.258786,"median":-7.5677,"eighty":-4.188571,"marketCap":72625777},{"date":"2023-05-19","current":-3.341253,"twenty":-19.131097,"median":-7.525445,"eighty":-4.170183,"marketCap":66731511},{"date":"2023-05-26","current":-3.272255,"twenty":-19.089695,"median":-7.447673,"eighty":-4.134387,"marketCap":65353468},{"date":"2023-06-02","current":-3.335589,"twenty":-19.058146,"median":-7.387659,"eighty":-4.092704,"marketCap":66618374},{"date":"2023-06-09","current":-3.683925,"twenty":-18.992181,"median":-7.321645,"eighty":-4.079031,"marketCap":73575356},{"date":"2023-06-16","current":-3.736704,"twenty":-18.952028,"median":-7.321645,"eighty":-4.058522,"marketCap":74629444},{"date":"2023-06-23","current":-3.905594,"twenty":-18.929084,"median":-7.309642,"eighty":-4.044458,"marketCap":78002526},{"date":"2023-06-30","current":-3.588662,"twenty":-18.929084,"median":-7.301414,"eighty":-4.030512,"marketCap":71672749},{"date":"2023-07-07","current":-3.175807,"twenty":-18.860251,"median":-7.29255,"eighty":-4.013656,"marketCap":63427212},{"date":"2023-07-14","current":-3.546317,"twenty":-18.797154,"median":-7.261631,"eighty":-3.988563,"marketCap":70827053},{"date":"2023-07-21","current":-3.662764,"twenty":-18.544766,"median":-7.231624,"eighty":-3.974726,"marketCap":73152717},{"date":"2023-07-28","current":-3.546317,"twenty":-18.384156,"median":-7.201618,"eighty":-3.956502,"marketCap":70827053},{"date":"2023-08-04","current":-3.592881,"twenty":-18.349739,"median":-7.160915,"eighty":-3.93091,"marketCap":71757024},{"date":"2023-08-11","current":-3.444503,"twenty":-18.137504,"median":-7.15835,"eighty":-3.920784,"marketCap":68793608},{"date":"2023-08-18","current":-2.948161,"twenty":-17.994102,"median":-7.123601,"eighty":-3.863042,"marketCap":58904262},{"date":"2023-08-25","current":-2.669745,"twenty":-17.955259,"median":-7.011512,"eighty":-3.835262,"marketCap":53341505},{"date":"2023-09-01","current":-2.976978,"twenty":-17.89555,"median":-6.993157,"eighty":-3.822281,"marketCap":59480011},{"date":"2023-09-08","current":-2.542614,"twenty":-17.822019,"median":-6.965625,"eighty":-3.811521,"marketCap":50801433},{"date":"2023-09-15","current":-2.468455,"twenty":-17.71877,"median":-6.915094,"eighty":-3.771793,"marketCap":49319725},{"date":"2023-09-22","current":-2.426078,"twenty":-17.667145,"median":-6.883029,"eighty":-3.718983,"marketCap":48473034},{"date":"2023-09-29","current":-2.415484,"twenty":-17.661835,"median":-6.856984,"eighty":-3.690753,"marketCap":48261361},{"date":"2023-10-06","current":-2.214193,"twenty":-17.636236,"median":-6.80961,"eighty":-3.659579,"marketCap":44239581},{"date":"2023-10-13","current":-1.980251,"twenty":-17.598312,"median":-6.754546,"eighty":-3.624757,"marketCap":39565422},{"date":"2023-10-20","current":-2.288554,"twenty":-17.523743,"median":-6.699481,"eighty":-3.58231,"marketCap":45725309},{"date":"2023-10-27","current":-2.252981,"twenty":-17.466382,"median":-6.699481,"eighty":-3.56025,"marketCap":45014553},{"date":"2023-11-03","current":-2.41899,"twenty":-17.391813,"median":-6.662772,"eighty":-3.546317,"marketCap":48331414},{"date":"2023-11-10","current":-2.288554,"twenty":-17.304698,"median":-6.589353,"eighty":-3.531279,"marketCap":45725309},{"date":"2023-11-17","current":-2.178562,"twenty":-17.149879,"median":-6.570998,"eighty":-3.505973,"marketCap":43227025},{"date":"2023-11-24","current":-2.334173,"twenty":-17.098914,"median":-6.552643,"eighty":-3.478451,"marketCap":46314670},{"date":"2023-12-01","current":-2.346144,"twenty":-17.022324,"median":-6.515934,"eighty":-3.46349,"marketCap":46552181},{"date":"2023-12-08","current":-2.836919,"twenty":-16.949803,"median":-6.479224,"eighty":-3.442885,"marketCap":56290137},{"date":"2023-12-15","current":-2.477815,"twenty":-16.925057,"median":-6.467164,"eighty":-3.432578,"marketCap":49164803},{"date":"2023-12-22","current":-1.496265,"twenty":-16.921454,"median":-6.42416,"eighty":-3.407935,"marketCap":29688891},{"date":"2023-12-29","current":-1.663847,"twenty":-16.915718,"median":-6.405805,"eighty":-3.364573,"marketCap":33014047},{"date":"2024-01-05","current":-1.695584,"twenty":-16.89851,"median":-6.405805,"eighty":-3.34012,"marketCap":33643786},{"date":"2024-01-12","current":-1.480473,"twenty":-16.87874,"median":-6.387451,"eighty":-3.281496,"marketCap":29375544},{"date":"2024-01-19","current":-1.290669,"twenty":-16.824266,"median":-6.369096,"eighty":-3.249023,"marketCap":25609449},{"date":"2024-01-26","current":-1.0338,"twenty":-16.696906,"median":-6.332386,"eighty":-3.205095,"marketCap":20512666},{"date":"2024-02-02","current":-0.646816,"twenty":-16.600233,"median":-6.314032,"eighty":-3.203217,"marketCap":12834128},{"date":"2024-02-09","current":-0.653022,"twenty":-16.577289,"median":-6.277322,"eighty":-3.193928,"marketCap":12957267},{"date":"2024-02-16","current":-0.672527,"twenty":-16.508456,"median":-6.194726,"eighty":-3.174121,"marketCap":13344276},{"date":"2024-02-23","current":-0.649223,"twenty":-16.446422,"median":-6.165475,"eighty":-3.13809,"marketCap":12881876},{"date":"2024-03-01","current":-0.626707,"twenty":-16.392461,"median":-6.13642,"eighty":-3.119242,"marketCap":13419668},{"date":"2024-03-08","current":-0.604507,"twenty":-16.347845,"median":-6.043444,"eighty":-3.086719,"marketCap":12944316},{"date":"2024-03-15","current":-0.539948,"twenty":-16.336373,"median":-6.031822,"eighty":-3.037469,"marketCap":11561914},{"date":"2024-03-22","current":-0.457797,"twenty":-16.307693,"median":-5.90979,"eighty":-3.001845,"marketCap":9802813},{"date":"2024-03-28","current":-0.365064,"twenty":-16.250332,"median":-5.706405,"eighty":-2.983977,"marketCap":7817112},{"date":"2024-04-05","current":-0.238289,"twenty":-16.024769,"median":-5.625051,"eighty":-2.958746,"marketCap":5102488},{"date":"2024-04-12","current":-0.306251,"twenty":-15.71519,"median":-5.52917,"eighty":-2.918711,"marketCap":6557744},{"date":"2024-04-19","current":-0.450382,"twenty":-15.453016,"median":-5.334501,"eighty":-2.841315,"marketCap":9644030},{"date":"2024-04-26","current":-0.561354,"twenty":-15.194892,"median":-5.069776,"eighty":-2.724673,"marketCap":12020274},{"date":"2024-05-03","current":-0.608414,"twenty":-15.170319,"median":-4.916109,"eighty":-2.66127,"marketCap":13027961},{"date":"2024-05-10","current":-0.517656,"twenty":-15.15399,"median":-4.882304,"eighty":-2.574397,"marketCap":11084564},{"date":"2024-05-17","current":-0.445886,"twenty":-14.962839,"median":-4.799889,"eighty":-2.544018,"marketCap":9285122},{"date":"2024-05-24","current":-0.341455,"twenty":-14.350128,"median":-4.694797,"eighty":-2.481196,"marketCap":7110458},{"date":"2024-05-31","current":-0.332309,"twenty":-14.32955,"median":-4.683289,"eighty":-2.468455,"marketCap":6920000},{"date":"2024-06-07","current":-0.320114,"twenty":-14.231403,"median":-4.68291,"eighty":-2.442705,"marketCap":6666055},{"date":"2024-06-14","current":-0.820102,"twenty":-14.17194,"median":-4.613937,"eighty":-2.429163,"marketCap":17077798},{"date":"2024-06-21","current":-0.746933,"twenty":-14.05445,"median":-4.603153,"eighty":-2.417588,"marketCap":15554128},{"date":"2024-06-28","current":-0.512182,"twenty":-13.986034,"median":-4.591759,"eighty":-2.404889,"marketCap":10665688},{"date":"2024-07-05","current":-0.503036,"twenty":-13.77177,"median":-4.557577,"eighty":-2.344112,"marketCap":10475229},{"date":"2024-07-12","current":-1.185946,"twenty":-13.57097,"median":-4.546183,"eighty":-2.334173,"marketCap":24696147},{"date":"2024-07-15","current":-2.024011,"twenty":-13.534162,"median":-4.546183,"eighty":-2.334173,"marketCap":42148012},{"date":"2024-08-02","current":-2.096274,"twenty":-13.516574,"median":-4.545194,"eighty":-2.334173,"marketCap":43652813},{"date":"2024-08-09","current":-1.758388,"twenty":-13.433225,"median":-4.520961,"eighty":-2.31064,"marketCap":36616668},{"date":"2024-08-16","current":-1.898646,"twenty":-13.364791,"median":-4.512001,"eighty":-2.29924,"marketCap":35324315},{"date":"2024-08-23","current":-2.029854,"twenty":-13.222936,"median":-4.500607,"eighty":-2.288554,"marketCap":37765427},{"date":"2024-08-30","current":-1.613078,"twenty":-12.914361,"median":-4.480896,"eighty":-2.277759,"marketCap":30011309},{"date":"2024-09-06","current":-1.667104,"twenty":-12.897094,"median":-4.462817,"eighty":-2.252981,"marketCap":31016472},{"date":"2024-09-13","current":-1.559051,"twenty":-12.854623,"median":-4.427985,"eighty":-2.217407,"marketCap":29006145},{"date":"2024-09-20","current":-1.589923,"twenty":-12.771457,"median":-4.406757,"eighty":-2.173128,"marketCap":29580524},{"date":"2024-09-27","current":-1.520461,"twenty":-12.501551,"median":-4.358253,"eighty":-2.075114,"marketCap":28288171},{"date":"2024-10-04","current":-1.381535,"twenty":-12.489283,"median":-4.29783,"eighty":-1.99284,"marketCap":25703465},{"date":"2024-10-11","current":-1.373817,"twenty":-12.472382,"median":-4.222264,"eighty":-1.970526,"marketCap":25559870},{"date":"2024-10-18","current":-1.705694,"twenty":-12.292987,"median":-4.207166,"eighty":-1.860056,"marketCap":31734446},{"date":"2024-10-25","current":-1.597641,"twenty":-12.243914,"median":-4.183922,"eighty":-1.813748,"marketCap":29724119},{"date":"2024-10-31","current":-1.667104,"twenty":-12.077063,"median":-4.181577,"eighty":-1.759454,"marketCap":31016472},{"date":"2024-11-08","current":-1.697976,"twenty":-12.005906,"median":-4.169657,"eighty":-1.745424,"marketCap":31590851},{"date":"2024-11-15","current":-1.666725,"twenty":-11.98873,"median":-4.149056,"eighty":-1.721811,"marketCap":29867714},{"date":"2024-11-22","current":-1.49845,"twenty":-11.899483,"median":-4.107516,"eighty":-1.702334,"marketCap":26852223},{"date":"2024-11-29","current":-1.697287,"twenty":-11.788297,"median":-4.084874,"eighty":-1.6977,"marketCap":30415388},{"date":"2024-12-06","current":-1.556537,"twenty":-11.581418,"median":-4.079031,"eighty":-1.693454,"marketCap":27893137},{"date":"2024-12-13","current":-1.539978,"twenty":-11.468548,"median":-4.06767,"eighty":-1.687171,"marketCap":27596401},{"date":"2024-12-20","current":-1.324712,"twenty":-11.370394,"median":-4.056243,"eighty":-1.669008,"marketCap":23738840},{"date":"2024-12-27","current":-1.523419,"twenty":-11.306598,"median":-4.044458,"eighty":-1.666877,"marketCap":27299666},{"date":"2025-01-03","current":-1.482022,"twenty":-11.23054,"median":-4.033455,"eighty":-1.660278,"marketCap":26557827},{"date":"2025-01-10","current":-1.49858,"twenty":-10.955726,"median":-4.021214,"eighty":-1.647611,"marketCap":26854562},{"date":"2025-01-17","current":-1.457183,"twenty":-10.946459,"median":-4.012979,"eighty":-1.632316,"marketCap":26112724},{"date":"2025-01-24","current":-1.407507,"twenty":-10.887398,"median":-3.998622,"eighty":-1.62215,"marketCap":25222517},{"date":"2025-01-31","current":-1.324712,"twenty":-10.772257,"median":-3.986348,"eighty":-1.60536,"marketCap":23738840},{"date":"2025-02-07","current":-1.332991,"twenty":-10.700305,"median":-3.974726,"eighty":-1.596984,"marketCap":23887207},{"date":"2025-02-14","current":-1.299874,"twenty":-10.597985,"median":-3.965092,"eighty":-1.589257,"marketCap":23293736},{"date":"2025-02-21","current":-1.35783,"twenty":-10.56684,"median":-3.958372,"eighty":-1.581873,"marketCap":24332311},{"date":"2025-02-28","current":-1.266756,"twenty":-10.5272,"median":-3.94548,"eighty":-1.573931,"marketCap":22700265},{"date":"2025-03-07","current":-1.337567,"twenty":-10.488832,"median":-3.93091,"eighty":-1.558045,"marketCap":21364956},{"date":"2025-03-14","current":-1.532696,"twenty":-10.409128,"median":-3.93091,"eighty":-1.545363,"marketCap":24481760},{"date":"2025-03-21","current":-1.644845,"twenty":-10.354484,"median":-3.896728,"eighty":-1.545363,"marketCap":26273109},{"date":"2025-03-28","current":-1.588771,"twenty":-10.300744,"median":-3.862959,"eighty":-1.549411,"marketCap":25377435},{"date":"2025-04-04","current":-1.355128,"twenty":-10.19785,"median":-3.839758,"eighty":-1.541216,"marketCap":21645459},{"date":"2025-04-11","current":-1.261671,"twenty":-10.150622,"median":-3.831813,"eighty":-1.530889,"marketCap":20152669},{"date":"2025-04-17","current":-1.317745,"twenty":-10.127971,"median":-3.8257,"eighty":-1.520461,"marketCap":21048343},{"date":"2025-04-22","current":-1.420548,"twenty":-10.10532,"median":-3.822093,"eighty":-1.506493,"marketCap":22690412}],"updateTime":1745422469581}}}